Cabot Corporation’s (CBT) Hold Rating Reiterated at KeyCorp

Cabot Corporation (NYSE:CBT)‘s stock had its “hold” rating reiterated by analysts at KeyCorp in a research report issued on Wednesday, November 1st.

A number of other equities research analysts have also weighed in on the stock. Loop Capital began coverage on shares of Cabot Corporation in a report on Thursday, September 28th. They set a “hold” rating and a $59.00 price target for the company. Zacks Investment Research upgraded shares of Cabot Corporation from a “sell” rating to a “hold” rating in a research note on Wednesday, August 16th. J P Morgan Chase & Co upgraded shares of Cabot Corporation from a “neutral” rating to an “overweight” rating and set a $57.00 price objective on the stock in a research note on Tuesday, August 15th. BidaskClub downgraded shares of Cabot Corporation from a “buy” rating to a “hold” rating in a research report on Monday, July 31st. Finally, ValuEngine downgraded shares of Cabot Corporation from a “buy” rating to a “hold” rating in a research report on Friday, July 28th. Six equities research analysts have rated the stock with a hold rating and four have assigned a buy rating to the company. The stock has a consensus rating of “Hold” and a consensus target price of $61.14.

Shares of Cabot Corporation (NYSE:CBT) opened at $60.59 on Wednesday. Cabot Corporation has a 52-week low of $50.21 and a 52-week high of $64.66. The stock has a market cap of $3,746.48, a price-to-earnings ratio of 17.65, a PEG ratio of 1.60 and a beta of 1.11. The company has a quick ratio of 1.17, a current ratio of 1.70 and a debt-to-equity ratio of 0.41.

Cabot Corporation (NYSE:CBT) last released its quarterly earnings data on Tuesday, October 31st. The specialty chemicals company reported $0.91 earnings per share (EPS) for the quarter, missing the consensus estimate of $0.93 by ($0.02). The business had revenue of $723.00 million during the quarter, compared to analyst estimates of $683.30 million. Cabot Corporation had a return on equity of 15.11% and a net margin of 8.87%. Cabot Corporation’s revenue was up 16.8% on a year-over-year basis. During the same period in the previous year, the company earned $1.00 EPS. research analysts forecast that Cabot Corporation will post 3.78 EPS for the current fiscal year.

ILLEGAL ACTIVITY NOTICE: This report was first published by BBNS and is owned by of BBNS. If you are accessing this report on another website, it was illegally copied and reposted in violation of international trademark & copyright legislation. The original version of this report can be read at https://baseballnewssource.com/markets/cabot-corporation-cbt-receives-hold-rating-from-keycorp/1749409.html.

In other news, insider Hobart Kalkstein sold 3,881 shares of Cabot Corporation stock in a transaction that occurred on Thursday, September 14th. The shares were sold at an average price of $53.39, for a total value of $207,206.59. Following the transaction, the insider now owns 27,736 shares of the company’s stock, valued at $1,480,825.04. The transaction was disclosed in a legal filing with the SEC, which is available at the SEC website. 2.50% of the stock is owned by insiders.

Several large investors have recently modified their holdings of CBT. AJO LP boosted its stake in shares of Cabot Corporation by 196.4% in the 2nd quarter. AJO LP now owns 918,731 shares of the specialty chemicals company’s stock valued at $49,088,000 after purchasing an additional 608,799 shares in the last quarter. Deprince Race & Zollo Inc. acquired a new position in Cabot Corporation during the 2nd quarter worth about $27,643,000. BlackRock Inc. lifted its position in Cabot Corporation by 7.2% during the 2nd quarter. BlackRock Inc. now owns 7,544,005 shares of the specialty chemicals company’s stock worth $403,077,000 after buying an additional 505,594 shares in the last quarter. Earnest Partners LLC lifted its position in Cabot Corporation by 41.8% during the 2nd quarter. Earnest Partners LLC now owns 1,491,521 shares of the specialty chemicals company’s stock worth $79,692,000 after buying an additional 439,350 shares in the last quarter. Finally, BNP Paribas Arbitrage SA lifted its position in Cabot Corporation by 433.2% during the 3rd quarter. BNP Paribas Arbitrage SA now owns 440,191 shares of the specialty chemicals company’s stock worth $24,563,000 after buying an additional 357,639 shares in the last quarter. Institutional investors own 84.77% of the company’s stock.

About Cabot Corporation

Cabot Corporation is a global specialty chemicals and performance materials company. The Company operates through four business segments: reinforcement materials, performance chemicals, purification solutions and specialty fluids. Reinforcement materials’ rubber grade carbon blacks are used to enhance the physical properties of the systems and applications in which they are incorporated.

Analyst Recommendations for Cabot Corporation (NYSE:CBT)

Receive News & Ratings for Cabot Corporation Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Cabot Corporation and related companies with our FREE daily email newsletter.

 


Latest News

Jack Morris, Alan Trammel Voted by Modern Era Committee into Hall of Fame
Jack Morris, Alan Trammel Voted by Modern Era Committee into Hall of Fame
Yankees and Marlins Continue Stanton Trade Talks
Yankees and Marlins Continue Stanton Trade Talks
Marlins Making Moves, Trade Dee Gordon to Seattle
Marlins Making Moves, Trade Dee Gordon to Seattle
Report: Astros Dallas Keuchel Pitched With Injured Foot
Report: Astros Dallas Keuchel Pitched With Injured Foot
Angels Sign Former Prospect with Braves Kevin Maitan
Angels Sign Former Prospect with Braves Kevin Maitan
Shohei Ohtani Has Turned Down Red Sox and Yankees
Shohei Ohtani Has Turned Down Red Sox and Yankees


Leave a Reply

 
© 2006-2017 BBNS.